Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000894189-25-003415
Filing Date
2025-05-02
Accepted
2025-05-02 10:42:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 9618
2 JOINT FILING AGREEMENT joint-agmt.htm EX-99.2 6477
  Complete submission text file 0000894189-25-003415.txt   17735
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Subject) CIK: 0001446847 (see all company filings)

EIN.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-85292 | Film No.: 25906194
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 500 CHESTERFIELD PARKWAY MALVERN PA 19355
Business Address 500 CHESTERFIELD PARKWAY MALVERN PA 19355 610-644-8100
Pacer Advisors, Inc. (Filed by) CIK: 0001616667 (see all company filings)

EIN.: 202687376 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G